MedPath

Philippines FDA Approvals

FDA Philippines approved pharmaceutical products and drug approvals

Food and Drug Administration of the Philippines
Philippines
30,876 Approvals
Showing 30701 to 30720 of 30,876 approvalsPage 1536 of 1544

Rapichlor

Issued: Aug 1, 2023

Amsudime -1.5

Issued: Aug 1, 2023

Guico-C

Issued: Aug 1, 2023

Hemovit

Issued: Aug 1, 2023

Unbranded

Issued: Aug 1, 2023

BIOLAC

Issued: Aug 1, 2023

Arnil

Issued: Aug 1, 2023

Tempmed

Issued: Aug 1, 2023

TieMac

Issued: Aug 1, 2023

Gavixone

Issued: Aug 1, 2023

Rapcenate Plus D

Issued: Aug 1, 2023

Spirenze

Issued: Aug 1, 2023

Dysport

Issued: Aug 1, 2023

H-CINE

Issued: Aug 1, 2023

Ambipen

Issued: Aug 1, 2023

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.